NPR Story
12:00 pm
Fri November 18, 2011

Geron To End Embryonic Stem Cell Research

Citing "capital scarcity" the Geron Corporation said it will abandon its research into using human embryonic stem cells to treat spinal cord injuries. Stem cell expert Leonard Zon discusses the announcement and what it means for the future of embryonic stem cell research.

Related Program